Cassava Historical Income Statement

SAVA Stock  USD 3.98  0.15  3.92%   
Historical analysis of Cassava Sciences income statement accounts such as Research Development of 93.9 M, Cost Of Revenue of 93.9 M, Total Operating Expenses of 111.3 M or Total Other Income Expense Net of 9.2 M can show how well Cassava Sciences performed in making a profits. Evaluating Cassava Sciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cassava Sciences's future profits or losses.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Cassava Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cassava Sciences is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.

About Cassava Income Statement Analysis

Cassava Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cassava Sciences shareholders. The income statement also shows Cassava investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Cassava Sciences Income Statement Chart

At present, Cassava Sciences' Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 4.6 M, whereas Gross Profit is projected to grow to (85 M).

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Cassava Sciences. It is also known as Cassava Sciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Cassava Sciences income statement and is an important metric when analyzing Cassava Sciences profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Net Income Applicable To Common Shares

The net income that remains after preferred dividends have been deducted, available to common shareholders.
Most accounts from Cassava Sciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cassava Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.At present, Cassava Sciences' Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 4.6 M, whereas Gross Profit is projected to grow to (85 M).
 2021 2022 2023 2024 (projected)
Net Interest Income49K2.8M7.8M8.2M
Interest Income49K2.8M7.8M8.2M

Cassava Sciences income statement Correlations

0.81-0.23-0.640.78-0.77-0.770.79-0.760.650.79-0.770.77-0.77-0.760.87-0.760.570.760.760.810.64-0.65
0.81-0.19-0.780.99-0.95-0.940.99-0.940.820.99-0.940.95-0.94-0.970.94-0.940.230.940.940.990.79-0.79
-0.23-0.190.49-0.20.460.48-0.210.48-0.19-0.210.48-0.180.490.19-0.170.48-0.04-0.19-0.18-0.22-0.150.15
-0.64-0.780.49-0.820.870.85-0.820.85-0.95-0.820.86-0.890.870.68-0.80.86-0.09-0.91-0.91-0.78-0.90.87
0.780.99-0.2-0.82-0.96-0.951.0-0.950.861.0-0.950.96-0.95-0.950.96-0.950.230.950.950.990.82-0.82
-0.77-0.950.460.87-0.961.0-0.961.0-0.81-0.961.0-0.921.00.92-0.921.0-0.22-0.9-0.9-0.96-0.780.76
-0.77-0.940.480.85-0.951.0-0.961.0-0.79-0.951.0-0.91.00.92-0.91.0-0.22-0.88-0.88-0.95-0.760.73
0.790.99-0.21-0.821.0-0.96-0.96-0.950.851.0-0.960.96-0.96-0.950.96-0.960.220.950.950.990.81-0.82
-0.76-0.940.480.85-0.951.01.0-0.95-0.79-0.951.0-0.91.00.92-0.91.0-0.21-0.88-0.88-0.95-0.760.73
0.650.82-0.19-0.950.86-0.81-0.790.85-0.790.86-0.80.94-0.81-0.70.85-0.80.10.960.960.810.94-0.94
0.790.99-0.21-0.821.0-0.96-0.951.0-0.950.86-0.950.97-0.95-0.950.96-0.950.230.950.950.990.82-0.82
-0.77-0.940.480.86-0.951.01.0-0.961.0-0.8-0.95-0.91.00.91-0.911.0-0.21-0.89-0.89-0.95-0.770.74
0.770.95-0.18-0.890.96-0.92-0.90.96-0.90.940.97-0.9-0.91-0.890.95-0.90.241.01.00.940.9-0.91
-0.77-0.940.490.87-0.951.01.0-0.961.0-0.81-0.951.0-0.910.91-0.911.0-0.21-0.9-0.9-0.95-0.780.75
-0.76-0.970.190.68-0.950.920.92-0.950.92-0.7-0.950.91-0.890.91-0.890.91-0.32-0.86-0.86-0.96-0.70.67
0.870.94-0.17-0.80.96-0.92-0.90.96-0.90.850.96-0.910.95-0.91-0.89-0.90.420.930.930.950.82-0.83
-0.76-0.940.480.86-0.951.01.0-0.961.0-0.8-0.951.0-0.91.00.91-0.9-0.21-0.89-0.89-0.95-0.770.74
0.570.23-0.04-0.090.23-0.22-0.220.22-0.210.10.23-0.210.24-0.21-0.320.42-0.210.190.190.250.14-0.15
0.760.94-0.19-0.910.95-0.9-0.880.95-0.880.960.95-0.891.0-0.9-0.860.93-0.890.191.00.930.92-0.92
0.760.94-0.18-0.910.95-0.9-0.880.95-0.880.960.95-0.891.0-0.9-0.860.93-0.890.191.00.930.92-0.92
0.810.99-0.22-0.780.99-0.96-0.950.99-0.950.810.99-0.950.94-0.95-0.960.95-0.950.250.930.930.78-0.79
0.640.79-0.15-0.90.82-0.78-0.760.81-0.760.940.82-0.770.9-0.78-0.70.82-0.770.140.920.920.78-0.8
-0.65-0.790.150.87-0.820.760.73-0.820.73-0.94-0.820.74-0.910.750.67-0.830.74-0.15-0.92-0.92-0.79-0.8
Click cells to compare fundamentals

Cassava Sciences Account Relationship Matchups

Cassava Sciences income statement Accounts

201920202021202220232024 (projected)
Gross Profit(1.6M)(346K)(534K)(1.8K)(89.4M)(85.0M)
Other Operating Expenses5.0M6.8M32.9M80.0M106.0M111.3M
Operating Income(5.0M)(6.4M)(32.9M)(80.0M)(106.0M)(100.7M)
Ebit(5.0M)(6.3M)(32.9M)(80.0M)(97.2M)(92.4M)
Research Development1.6M3.1M24.8M68.0M89.4M93.9M
Ebitda(4.9M)(6.3M)(32.3M)(78.7M)(95.7M)(90.9M)
Cost Of Revenue1.6M346K534K1.3M89.4M93.9M
Total Operating Expenses5.0M6.8M32.9M80.0M106.0M111.3M
Income Before Tax(4.6M)(6.3M)(32.4M)(76.2M)(97.2M)(92.4M)
Total Other Income Expense Net328K458K483K3.8M8.7M9.2M
Net Income(4.2M)(5.9M)(31.8M)(72.5M)(97.2M)(92.4M)
Income Tax Expense(386K)(480K)(583K)(3.8M)(3.4M)(3.2M)
Selling General Administrative3.4M3.7M8.1M12.0M16.5M17.4M
Net Income From Continuing Ops(4.6M)(6.3M)(32.4M)(76.2M)(97.2M)(92.4M)
Non Operating Income Net Other105K328K112K483K434.7K456.4K
Net Income Applicable To Common Shares(4.6M)(6.3M)(32.4M)(76.2M)(68.6M)(65.2M)
Interest Income328K112K49K2.8M7.8M8.2M
Net Interest Income328K112K49K2.8M7.8M8.2M
Reconciled Depreciation58K22K534K1.3M1.5M1.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Cassava Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cassava Sciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cassava Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cassava Sciences Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.38)
Return On Assets
(0.46)
Return On Equity
(0.11)
The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.